Cellular immunity induced by a recombinant adenovirus- human dendritic cell vaccine for melanoma

BACKGROUND: Human Adenoviral vectors (HAdV) are immunogenic vectors which have been tested in many vaccination and gene therapy settings. Dendritic cells (DC) transduced by genetically engineered HAdV-5 (HAdV-5/DC), are investigational cancer vaccines being tested clinically. We have previously exam...

Descripción completa

Detalles Bibliográficos
Autores principales: Naveh, Hadas Prag, Vujanovic, Lazar, Butterfield, Lisa H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019908/
https://www.ncbi.nlm.nih.gov/pubmed/24829755
http://dx.doi.org/10.1186/2051-1426-1-19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019908/
https://www.ncbi.nlm.nih.gov/pubmed/24829755
http://dx.doi.org/10.1186/2051-1426-1-19

Ejemplares similares